EUVIMEDEUVIMED entdecken
Open Access

Beyond Hybrid Morphology: A Large Series of Fusion-Driven Benign Peripheral Nerve Sheath Tumors Including 5 Tumors With Novel Fusions

Carina A Dehner, Tania Platero-Portillo, George Jour, Carla Saoud, Yanming Zhang, Darya Buehler, Meera Hameed, Michael Michal, Darcy Kerr, Klaus J Busam, Abbas Agaimy, Jorge Torres-Mora und 2 weitere

Modern Pathology · 2025-10 · 38 (10) · 100806

DOI: 10.1016/j.modpat.2025.100806 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2025-10. Verfasst von Carina A Dehner und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana. Hauptthemen laut MEDLINE: Nerve Sheath Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Memorial Sloan Kettering Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Benign peripheral nerve sheath tumors (PNSTs) represent a heterogeneous group of neoplasms with varying histologic and molecular characteristics. Although traditional classifications categorize these tumors based on predominant cell types, recent advances in molecular pathology have revealed the presence of hybrid tumors featuring elements from at least 2 nerve sheath tumors (hybrid peripheral nerve sheath tumor [hPNST]). We herein studied 20 cases of hPNST involving 15 female and 5 male patients (median age, 29.5 years; range, 3 weeks-71 years). Tumors occurred on the upper extremity (6), scalp (3), trunk (3), face (3), lower extremity (2), right lateral neck (1), nasal sinus (1), and retroperitoneum (1). Follow-up information was available in 9 of 20 cases (45%; median, 10 months; range, 2 weeks-144 months) and documented local recurrence in 2 of 9 patients (22%) at 10 and 144 months after incomplete excision. Next-generation sequencing demonstrated vestigial-like family member 3 (VGLL3) fusions in 14 cases, fused with CHD7 (10 tumors), CHD9 (3 tumors), and MAMLD1 (1 tumor), an alternative TEAD1::NCOA2 (1 tumor) fusion and several novel fusions including TOX::TEAD1 (2 tumors), RREB1::LPP (1 tumor), SRF::MYOCD (1 tumor), and KANK1::CDK5RAP2 (1 tumor). Most tumors with VGLL3 fusions showed morphologically and immunophenotypically classic features of hybrid schwannoma-perineurioma, whereas rare cases showed unusual microscopic features, such as prominent myxoid stroma, pseudolipoblasts, prominent Schwannian nodules, or solely schwannomatous morphology. The RREB1::LPP-driven tumor showed features of hybrid schwannoma-neurofibroma. Lastly, 1 tumor with a novel SRF::MYOCD fusion displayed morphologic features reminiscent of desmoplastic melanoma although exhibiting a combined neural and smooth muscle phenotype. Our data expand on the morphologic and molecular spectrum of fusion-driven hPNSTs, including 5 previously undescribed fusions, and further expand on noncentral nervous system schwannomas with VGLL3 fusions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nerve Sheath NeoplasmsHumansMaleFemaleChildMiddle AgedAdolescentAdultChild, PreschoolAgedYoung AdultInfantInfant, NewbornBiomarkers, TumorGene FusionNeurilemmomaOncogene Proteins, Fusion

Stichwörter der Autor:innen

TEAD1VGLL3hybrid nerve sheath tumorschwannoma-perineurioma

Substanzen

Biomarkers, TumorOncogene Proteins, Fusion

Autor:innen und Institutionen

  • Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana.
  • Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas.
  • Department of Dermatology, New York University Langone Health, New York, New York.
  • Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
  • Department of Pathology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic; Bioptical Laboratory Ltd, Pilsen, Czech Republic.

Förderung

  • NCI NIH HHS
  • Memorial Sloan Kettering Cancer Center

Zitieren

APA

Dehner, C. A., Platero-Portillo, T., Jour, G., Saoud, C., Zhang, Y., Buehler, D., Hameed, M., Michal, M., Kerr, D., Busam, K. J., Agaimy, A., Torres-Mora, J., Antonescu, C. R., & Linos, K. (2025). Beyond Hybrid Morphology: A Large Series of Fusion-Driven Benign Peripheral Nerve Sheath Tumors Including 5 Tumors With Novel Fusions. Modern Pathology, 38(10), 100806. https://doi.org/10.1016/j.modpat.2025.100806

Vancouver

Dehner CA, Platero-Portillo T, Jour G, Saoud C, Zhang Y, Buehler D, et al. Beyond Hybrid Morphology: A Large Series of Fusion-Driven Benign Peripheral Nerve Sheath Tumors Including 5 Tumors With Novel Fusions. Modern Pathology. 2025;38(10):100806. doi:10.1016/j.modpat.2025.100806

BibTeX
@article{Dehner2025,
  author = {Dehner, Carina A and Platero-Portillo, Tania and Jour, George and Saoud, Carla and Zhang, Yanming and Buehler, Darya and Hameed, Meera and Michal, Michael and Kerr, Darcy and Busam, Klaus J and Agaimy, Abbas and Torres-Mora, Jorge and Antonescu, Cristina R and Linos, Konstantinos},
  title = {Beyond Hybrid Morphology: A Large Series of Fusion-Driven Benign Peripheral Nerve Sheath Tumors Including 5 Tumors With Novel Fusions},
  journal = {Modern Pathology},
  year = {2025},
  volume = {38},
  number = {10},
  pages = {100806},
  doi = {10.1016/j.modpat.2025.100806}
}
Kostenlos starten →